Envoy Medical Inc. Class A (COCH)
NASDAQ: COCHHealth CareIndustrial SpecialtiesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
COCH stock chart
Technical analysisKey statistics
All statistics- Market cap
- $51.89M
- EPS (TTM)
- -$4.57
- Dividend yield
- None
- 52-week range
- 3.63 – 9.54
- Day range
- 6.52 – 6.85
- Volume / Avg
- 25.31K / 16.73K
- Beta
- —
- Shares outstanding
- 7.74M
52-week range
COCH stock today
Envoy Medical (COCH) closed at $6.70 on Nov 20, essentially unchanged from the prior close, versus the S&P 500's 3.70% decline. Shares are 29.8% below their 52-week high of $9.54 and 84.6% above the 52-week low of $3.63, in the middle of the past year's range. COCH is up 913.6% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 829.3%.
Envoy Medical has posted a net loss over the last twelve months (EPS of -$4.57), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Envoy Medical
Company profileEnvoy Medical, Inc., a hearing health company, provides medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants.
- Sector
- Health Care
- Industry
- Industrial Specialties
- CEO
- Mr. Brent T. Lucas Esq.
- Headquarters
- White Bear Lake, MN
- Employees
- 43
- IPO year
- 2021
- Website
- envoymedical.com
Financial highlights
Full financialsIn fiscal 2025, Envoy Medical generated $241,000 in revenue, up 7.1% from fiscal 2024. Envoy Medical reported a net loss of $23.8 million, compared with a loss of $20.8 million a year earlier. Gross margin was -262.7% (down from -229.8%) and operating margin -9240.7%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $241.00K | $225.00K | $316.00K | $237.00K | — |
| Growth | +7.11% | -28.80% | +33.33% | — | — |
| Net income | $-23.76M | $-20.80M | $-29.92M | $-15.92M | $-251.63K |
| EPS (diluted) | $-1.23 | $-1.49 | $-2.54 | $-1.57 | — |
Analyst forecast
ForecastConsensus (3 analysts)
strong_buy
Avg. price target
$2.17-67.61%
- Strong buy 0
- Buy 3
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 5, 2026
- EPS actual vs est.
- $-0.50 vs $-0.70
- Surprise
- +28.57%
COCH news
All COCH news- Envoy Medical, Inc. Reports Third Quarter 2026 Financial ResultsNasdaq
- Envoy Medical Consensus Price Target Increased by 899.99% to $22.10NasdaqCOCH, HEI.A
- Envoy Medical, Inc. Announces 1-for-10 Reverse Stock SplitNasdaqCOCH, WSO.B
- IQVIA Holdings (IQV) Surpasses Q3 Earnings and Revenue EstimatesNasdaqIQV, COCH
- Waters (WAT) Earnings Expected to Grow: Should You Buy?NasdaqWAT, COCH
Envoy Medical peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| YDDLOne and One Green Technologies. Inc Class A | 0.91 | 0.00% | $50.99M | vs COCH |
| CNXUConexeu Sciences Inc. | 1.55 | -25.48% | $47.79M | vs COCH |
| NTRBNutriband Inc. | 4.92 | -1.60% | $59.81M | vs COCH |
| APTAlpha Pro Tech Ltd. | 5.96 | -4.49% | $61.17M | vs COCH |
| WBXWallbox N.V. Class A | 1.49 | -13.87% | $36.14M | vs COCH |
| MAMOMassimo Group | 0.8405 | +3.40% | $35.00M | vs COCH |
| NTICNorthern Technologies International Corporation | 7.38 | -1.99% | $71.09M | vs COCH |
| MYOMyomo Inc. | 0.811 | -3.45% | $32.52M | vs COCH |
Indexes, lists and sector
Envoy Medical stock FAQ
What is Envoy Medical's stock price today?
COCH last traded at $6.70 as of Nov 20, 4:00 PM EST, up 0.00% on the day. Prices are delayed at least 15 minutes.
Does Envoy Medical pay a dividend?
No. Envoy Medical does not currently pay a regular cash dividend.
Who is Envoy Medical's CEO?
Mr. Brent T. Lucas Esq. is the chief executive officer of Envoy Medical Inc. Class A, which has about 43 employees.
Has COCH ever split its stock?
Yes. The most recent COCH stock split was a 1-for-10 split on Oct 26, 2026.
What is the COCH 52-week high?
The 52-week high for COCH is $9.54 and the 52-week low is $3.63. The stock is currently 29.8% below its high.